American Vanguard (AVD) 8-K American Vanguard Reports Second Quarter & Mid-year 2014 Results

Exhibit 99.1

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER & MID-YEAR 2014 RESULTS

Performance Reflects Reduced Channel Restocking and Lower Manufacturing Utilization

Newport Beach, CA – July 31, 2014 – American Vanguard Corporation (NYSE:AVD) announced financial results for the second quarter and six month period ended June 30, 2014.

Fiscal 2014 Second Quarter Financial Highlights – versus Fiscal 2013 Second Quarter:

• Net sales of $68.3 million, compared with $86.8 million

• Net income of $0.1 million, compared with $8.4 million

• Earnings per diluted share were $0.01, compared with $0.29

Fiscal 2014 First Half Financial Highlights – versus Fiscal 2013 First Half

• Net sales of $149.4 million, compared with $208.3 million

• Net income of $2.3 million, compared with $25.3 million

• Earnings per diluted share were $0.08, compared with $0.88

Note: Complete details are available in the financial schedules attached to this press release

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “As we previously reported, surplus inventory of corn products in the agriculture distribution channel resulted in significantly lower re-stocking procurement from manufacturers this season. Additionally, as we indicated, reduced production of these products in our manufacturing facilities has resulted in increased unabsorbed fixed factory costs which have negatively impacted profitability for the quarter and year to date.”

Mr. Wintemute concluded: “We believe that channel inventories have been reduced significantly this spring and that more normal purchasing patterns are likely to resume for the 2015 season which should start later this year and into the pre-planting months of 2015. We are undertaking cost reduction programs to right-size our manufacturing function with the product demand that we are forecasting. We have trimmed our operating expenses and will remain disciplined in our capital expenditures. We look forward to providing additional color on business and financial conditions in our earnings call later today.”

Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 4:30 pm ET / 1:30 pm PT on Thursday, July 31, 2014. Interested parties may participate in the call by dialing (201) 493-6744. Please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via theNews and Media section of the Company’s web site atwww.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

1

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000^® and Russell 3000^® Indexes as well as the S&P Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site atwww.amvac-chemical.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

Company Contact:	Investor Representative
American Vanguard Corporation	The Equity Group Inc.
William A. Kuser	www.theequitygroup.com
Director of Investor Relations	Lena Cati
(949) 260-1200	(212) 836-9611
williamk@amvac-chemical.com	Lcati@equityny.com

2

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

	For the three months ended June 30						For the six months ended June 30
	2014			2013			2014			2013
Net sales	$	68,313		$	86,761		$	149,408		$	208,298
Cost of sales		42,253			44,695			94,443			112,451
Gross profit		26,060			42,066			54,965			95,847
Operating expenses		25,337			29,169			50,280			56,798
Operating income		723			12,897			4,685			39,049
Interest expense		857			701			1,488			1,248
Less interest capitalized		(13	)		(31	)		(31	)		(225	)
(Loss) income before income taxes and loss on equity investment		(121	)		12,227			3,228			38,026
Income taxes (benefit) expense		(160	)		3,961			856			12,941
Income before loss on equity investment		39			8,266			2,372			25,085
Deduct net loss from equity method investment		(68	)		—			(396	)		—
Net (loss) income		(29	)		8,266			1,976			25,085
Add back net loss attributable to non-controlling interest		174			120			328			216
Net income attributable to American Vanguard Corporation		145			8,386			2,304			25,301
Change in fair value of interest rate swaps		145			174			281			352
Foreign currency translation adjustment		92			(476	)		143			(69	)
Comprehensive income	$	382		$	8,084		$	2,728		$	25,584
Earnings per common share—basic	$	.01		$	.29		$	.08		$	.89
Earnings per common share—assuming dilution	$	.01		$	.29		$	.08		$	.88
Weighted average shares outstanding—basic		28,408			28,295			28,404			28,280
Weighted average shares outstanding—assuming dilution		28,795			28,886			28,877			28,884

3

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

ASSETS

	June 30, 2014			Dec. 31, 2013
Current assets:
Cash and cash equivalents	$	4,189		$	6,680
Receivables:
Trade, net of allowance for doubtful accounts of $414 and $392, respectively		73,239			74,060
Other		2,738			892
Total receivables		75,977			74,952
Inventories		175,240			139,830
Prepaid expenses		14,049			11,435
Income taxes receivable		10,230			10,088
Deferred income tax assets		6,521			6,521
Total current assets		286,206			249,506
Property, plant and equipment, net		51,621			52,468
Intangible assets, net of applicable amortization		103,865			107,007
Other assets		37,750			38,462
	$	479,442		$	447,443
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current installments of long-term debt	$	70		$	69
Current installments of other liabilities		1,440			2,132
Accounts payable		23,900			40,702
Deferred revenue		1,512			3,788
Accrued program costs		74,359			53,630
Accrued expenses and other payables		5,996			10,178
Total current liabilities		107,277			110,499
Long-term debt, excluding current installments		86,091			51,676
Other liabilities, excluding current installments		3,981			4,143
Deferred income tax liabilities		23,002			23,330
Total liabilities		220,351			189,648
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued		—			—
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 31,528,400 shares at June 30, 2014 and 31,092,782 shares at December 31, 2013		3,153			3,109
Additional paid-in capital		63,380			60,160
Accumulated other comprehensive loss		(624	)		(1,048	)
Retained earnings		201,937			202,470
		267,846			264,691
Less treasury stock, at cost, 2,450,634 shares at June 30, 2014 and 2,380,634 shares at December 31, 2013		(8,269	)		(6,738	)
American Vanguard Corporation stockholders’ equity		259,577			257,953
Non-controlling interest		(486	)		(158	)
Total stockholders’ equity		259,091			257,795
	$	479,442		$	447,443

4

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For The Six Months Ended June 30, 2014 and 2013

(Unaudited)

Increase (decrease) in cash	2014			2013
Cash flows from operating activities:
Net income	$	1,976		$	25,085
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization of fixed and intangible assets		7,996			7,461
Amortization of other long term assets		3,027			1,802
Amortization of discounted liabilities		175			86
Stock-based compensation		1,806			1,747
Tax benefit from exercise of stock options		(262	)		(57	)
Loss from equity method investment		396			—
Gain on dilution of equity method investment		(256	)		—
Changes in assets and liabilities associated with operations:
(Increase) decrease in net receivables		(1,025	)		8,513
Increase in inventories		(35,410	)		(39,199	)
Increase in prepaid expenses and other assets		(5,069	)		(9,837	)
Decrease (increase) in income tax receivable		120			(1,404	)
Decrease in accounts payable		(16,521	)		(8,532	)
Decrease in deferred revenue		(2,276	)		(20,149	)
Increase in other payables and accrued expenses		16,264			54,529
Net cash (used in) provided by operating activities		(29,059	)		20,045
Cash flows from investing activities:
Capital expenditures		(3,954	)		(8,360	)
Investment		—			(3,687	)
Net cash used in investing activities		(3,954	)		(12,047	)
Cash flows from financing activities:
Net borrowings under line of credit agreement		34,450			40,750
Payments on long-term debt		—			(46,000	)
Payments on other long-term liabilities		(1,109	)		(1,238	)
Tax benefit from exercise of stock options		262			57
Decrease in other notes payable		—			(6,154	)
Repurchases of common stock		(1,531	)		—
Payment of cash dividends		(2,836	)		(1,976	)
Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock options)		1,196			527
Net cash provided by (used in) financing activities		30,432			(14,034	)
Net decrease in cash and cash equivalents		(2,581	)		(6,036	)
Cash and cash equivalents at beginning of period		6,680			38,476
Effect of exchange rate changes on cash		90			(26	)
Cash and cash equivalents as of the end of the period	$	4,189		$	32,414

5